Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAMA: EVLA vs MOCA for Varicose Veins
NCT02627846Phase 4Completed
- Sponsor
- Hull University Teaching Hospitals
- Start
- Jun 2015
- Primary completion
- Aug 2018
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Hull University Teaching Hospitals. Primary endpoints: Intra-procedural Pain and Technical Efficacy at 1 year. Started Jun 2015; status: completed.
Beyond the preview
Go deeper on NCT02627846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02627846.